NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

SEATTLE–(BUSINESS WIRE). 2022 AGBT AGM in Orlando, FL. Conference attendees will have the opportunity to preview AtoMx SIP at the symposium on Monday, June 6, 2022 from 12:00 p.m. to 4:00 p.m. EDT. The event will be streamed live and will be held in person. Visit the Spatial Multiomics Symposium – NanoString to register.

The AtoMx SIP is a new cloud-based informatics portal that will provide an integrated ecosystem with streamlined workflows to manage, analyze and share data from NanoString’s GeoMx® Digital Spatial Profiler (DSP) and CosMx™ Spatial Molecular Imager (SMI) platforms . AtoMx offers spatial biology researchers a scalable solution that reduces computing times from days to hours and enables secure data exchange and collaboration between laboratories and institutions.

AtoMx aims to revolutionize multi-omics spatial data analysis by leveraging the unlimited computing power and storage capacities of the cloud. AtoMx will enable researchers to easily access, visualize, collaborate, analyze and securely store data at a scale not available in the spatial biology market.

AtoMx provides an integrated platform for working with spatial biology data from multiple instrument systems. Built on cloud infrastructure, AtoMx provides computational capabilities that scale with datasets and the complexity of the analytics pipeline. In addition, AtoMx provides easy access to analysis methods for CosMX SMI via a pipeline orchestrator that allows users to create custom analysis pipelines, and for GeoMx DSP, the system provides all up-to-date local data analysis tools in the cloud.

As data sets become available within AtoMx, the platform will enable new and innovative multi-omics data analysis methods based on artificial intelligence.

“The AtoMx Spatial Informatics Portal addresses the challenges of data analysis and informatics in spatial biology and significantly expands the impact of our GeoMx DSP and CosMx SMI platforms,” ​​said Brad Gray, President and CEO of NanoString. “We expect the new AtoMx informatics portal to democratize spatial biology at scale and provide an unprecedented informatics platform to unleash the full potential of spatial biology research.”

AtoMx SIP is provided as a Software-as-a-Service (SaaS) offering for the academic research and pharma/biotech markets. In addition, a Virtual Private Cloud (VPC) offering is planned for those customers who may need more direct control over their data. AtoMx SIP is currently in beta testing and is expected to launch commercially in Fall 2022.

For more information on the AtoMx SIP, visit www.nanostring.com/atomx.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company offers three platforms that enable researchers to map the universe of biology. Cited in more than 5,300 peer-reviewed publications, the nCounter® analysis system provides a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations simultaneously with high sensitivity and precision. NanoString’s GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in more than 120 peer-reviewed publications. Expected for commercial availability in 2022, the CosMx Spatial Molecular Imager enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells in morphologically intact whole tissue sections. Visit www.nanostring.com for more information.

NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements about our products and the anticipated introduction of new products and technologies . Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include market acceptance of our products; the magnitude and duration of the impact of the COVID-19 pandemic and adverse conditions in general domestic and global economic markets; the impact of ongoing litigation; the effects of competition; the impact of expanded sales, marketing, product development and clinical activities on operating costs; delays or other unforeseen issues relating to manufacturing and product development; and the other risks detailed in our filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this release. NanoString Technologies disclaims any obligation to update these forward-looking statements.

NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.